A “Click Chemistry Platform” for the Rapid Synthesis of Bispecific Molecules for Inducing Protein Degradation
Author:
Affiliation:
1. Department of Therapeutic Discovery−Discovery Technologies, Amgen Inc., 1120 Veterans Boulevard, South San Francisco, California 94080, United States
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.6b01781
Reference23 articles.
1. Small-Molecule PROTACS: New Approaches to Protein Degradation
2. Induced protein degradation: an emerging drug discovery paradigm
3. New insights into ubiquitin E3 ligase mechanism
4. Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells
5. Catalytic in vivo protein knockdown by small-molecule PROTACs
Cited by 139 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. FLT3-PROTACs for combating AML resistance: Analytical overview on chimeric agents developed, challenges, and future perspectives;European Journal of Medicinal Chemistry;2024-11
2. Synthesis, SAR, and application of JQ1 analogs as PROTACs for cancer therapy;Bioorganic & Medicinal Chemistry;2024-10
3. An updated patent review of BRD4 degraders;Expert Opinion on Therapeutic Patents;2024-09-04
4. Discovery of novel nitrofuran PROTAC-like compounds as dual inhibitors and degraders targeting STING;European Journal of Medicinal Chemistry;2024-09
5. PROTAC unleashed: Unveiling the synthetic approaches and potential therapeutic applications;European Journal of Medicinal Chemistry;2024-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3